Moreover, anti-Sema4D Ab delayed tumor growth and prolonged survival by 29% in a murine colon cancer model (Evans et al., 2015) and Sema4D silencing by RNA interference reduced the breast cancer related bone metastasis (Yang et al., 2016). The gene discussed is SEMA4D; the disease is neoplasm.